InvestorsHub Logo
Followers 240
Posts 12420
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Friday, 07/17/2020 3:14:18 PM

Friday, July 17, 2020 3:14:18 PM

Post# of 705383
I don't believe it's possible to say with absolute certainty that the FDA will approve a drug. That stated, I don't believe that anyone looking at what we believe will be in the TLD not to be enthusiastic about what the vaccine has achieved. If I'm right about that, I can't see the share price not being substantially higher over roughly the next year or so while we're going through the approval process by the FDA and other regulators.

Personally, I believe at some point between now and then a partnership is likely, and that will establish a new trading range for the stock, and in some way act as a cushion should the FDA demand some further proof before the vaccine could be approved. Meanwhile, hopefully, DCVax-Direct will initiate further trials, and perhaps there will be a readout of that trial by the time the regulators act on DCVax-L. If all of this occurs in a positive manner, the ultimate potential of NWBO having a triple digit market cap in time should certainly be seen. If someone is interested in acquiring the company, they should realize the kind of money they'll need to offer to make it happen.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News